HMC
Harvard Management Company Portfolio holdings
AUM
$1.44B
This Quarter Return
-20.41%
1 Year Return
+33.17%
3 Year Return
+230.83%
5 Year Return
+163.57%
10 Year Return
+194.2%
AUM
$864M
AUM Growth
+$864M
(-13%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
11.75%
Top 10 Holdings %
Top 10 Hldgs %
81.94%
Holding
45
New
1
Increased
11
Reduced
1
Closed
–
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$73M |
| 2 |
ASML
ASML
|
$9.61M |
| 3 |
NVIDIA
NVDA
|
$6.07M |
| 4 |
Qorvo
QRVO
|
$5.44M |
| 5 |
Advanced Micro Devices
AMD
|
$4.4M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$15.3M |
Sector Composition
| 1 | Communication Services | 51.63% |
| 2 | Healthcare | 17.75% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Technology | 12.1% |
| 5 | Industrials | 2.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alphabet (Google) Class A
GOOGL
$2.57T
| $263M | 30.42% |
120,577
+33,490
| +38% | +$73M |
|
|
2
Meta Platforms (Facebook)
META
$1.86T
| $183M | 21.21% |
1,135,916
-95,103
| -8% | -$15.3M |
|
3
Light & Wonder
LNW
$7.76B
| $126M | 14.57% |
2,678,571
| – | – |
|
4
AbCellera Biologics
ABCL
$1.25B
| $43.7M | 5.06% |
4,105,095
| – | – |
|
|
EQRX
5
DELISTED
EQRx, Inc. Common Stock
EQRX
| $24.7M | 2.86% |
5,262,161
| – | – |
|
6
PureCycle Technologies
PCT
$2.57B
| $18.5M | 2.15% |
2,498,170
| – | – |
|
7
Grab
GRAB
$20.3B
| $13.6M | 1.57% |
5,369,919
+1,684,959
| +46% | +$4.26M |
|
8
Revolution Medicines
RVMD
$7.1B
| $13.1M | 1.51% |
670,382
| – | – |
|
9
Recursion Pharmaceuticals
RXRX
$2.04B
| $12.3M | 1.42% |
1,509,254
| – | – |
|
|
10
NVIDIA
NVDA
$4.24T
| $10.1M | 1.16% |
66,368
+40,053
| +152% | +$6.07M |
|
|
MEKA
11
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $9.9M | 1.15% |
1,000,000
| – | – |
|
|
12
Qorvo
QRVO
$8.4B
| $9.87M | 1.14% |
104,669
+57,706
| +123% | +$5.44M |
|
|
13
ASML
ASML
$292B
| $9.61M | 1.11% |
+20,186
| New | +$9.61M |
|
14
Relay Therapeutics
RLAY
$619M
| $9.06M | 1.05% |
541,124
| – | – |
|
15
TSMC
TSM
$1.2T
| $8.77M | 1.02% |
107,294
+42,851
| +66% | +$3.5M |
|
|
16
Advanced Micro Devices
AMD
$264B
| $8.58M | 0.99% |
112,137
+57,527
| +105% | +$4.4M |
|
17
10x Genomics
TXG
$1.74B
| $8.42M | 0.98% |
186,143
| – | – |
|
18
Lam Research
LRCX
$127B
| $8.15M | 0.94% |
19,131
+6,610
| +53% | +$2.82M |
|
19
Applied Materials
AMAT
$128B
| $8.05M | 0.93% |
88,443
+37,890
| +75% | +$3.45M |
|
20
Analog Devices
ADI
$124B
| $7.97M | 0.92% |
54,568
+12,829
| +31% | +$1.87M |
|
21
Intel
INTC
$107B
| $7.77M | 0.9% |
207,752
+56,946
| +38% | +$2.13M |
|
|
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $6.28M | 0.73% |
498,001
| – | – |
|
23
Micron Technology
MU
$133B
| $5.94M | 0.69% |
107,522
+4,838
| +5% | +$267K |
|
24
Pliant Therapeutics
PLRX
$101M
| $4.51M | 0.52% |
562,379
| – | – |
|
25
Nurix Therapeutics
NRIX
$714M
| $3.99M | 0.46% |
314,762
| – | – |
|